SELECT LANGUAGE BELOW

Reasons for the Decline in Intuitive Surgical Stock This Week

Reasons for the Decline in Intuitive Surgical Stock This Week

Shares of Intuitive Surgical (NASDAQ: ISRG) experienced a decline last week as worries grew regarding a potential slowdown in the company’s growth trajectory.

Strong Second Quarter Results

In the second quarter, Intuitive reported a 16% increase year-over-year in procedures performed globally. The use of its da Vinci robotic surgical platform rose by 15%, while the Ion robot-assisted platform for minimally invasive lung biopsies saw a remarkable 36% surge.

During this quarter, Intuitive installed 468 da Vinci systems and 55 Ion systems, boosting the total number of da Vinci systems to 11,710—representing a 12% increase—and the Ion systems to 1,096, which is a 21% rise.

Overall, the company saw a 19% jump in revenue, reaching $2.9 billion. This growth resulted from higher system leasing fees and sales of equipment and accessories.

Intuitive’s adjusted net income also grew 25% to $1 billion, translating to $2.80 per share, exceeding analysts’ expectations of $2.50 earnings per share.

Intuitive’s Outlook Suggests Slower Growth Ahead

However, researchers note that investors are increasingly focused on the outlook for the second half of the year. Management indicated that da Vinci surgery growth is expected to fall within a range of 13.5% to 15.5%. Despite exceeding expectations in the second quarter, the company decided not to increase its full-year forecast, suggesting that growth might decelerate for the remaining months.

This cautious outlook prompted Wall Street to lower Intuitive’s price target multiple times, leading many investors to sell their shares.

Should You Buy Intuitive Surgical Stock Now?

Before making any investment in Intuitive Surgical stock, there are some factors to ponder:

An analyst team recently identified top stocks for current investment, and surprisingly, Intuitive Surgical wasn’t included among the ten best. The stocks on that list appear geared for long-term growth, promising considerable returns in the coming years.

Past performances of recommended stocks show impressive gains. For example, had one invested $1,000 into Netflix back when it was recommended, that investment could now be valued at around $371,842. Similarly, an early investment in Nvidia would stand at approximately $1,244,783 today.

This kind of performance captures attention, and it’s no wonder that many people follow these recommendations. With a reputation for outperforming the S&P 500 significantly, the stock advisor community doesn’t shy away from sharing its latest top picks.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News